MYL Related Analyst Ratings

Sep 30, 2009 07:31 AM Goldman Sachs Raises Price Targets for Healthcare Services; Upgrades ABC, Downgrades PSSI

Sep 23, 2009 12:30 PM Standard & Poor's Upgrades Mylan (MYL) Credit Rating to 'BB'

Sep 9, 2009 09:24 AM Caris & Co Downgrades Mylan (MYL) to Average

Jun 19, 2009 11:52 AM FTN Equity Starts Mylan Labs (MYL) at Neutral

May 28, 2009 07:20 AM Goldman Sachs Removed Mylan (MYL) from its Conviction Buy List

May 14, 2009 08:52 AM Bernstein downgrades Mylan Labs (MYL) to Market Perform

Apr 23, 2009 08:13 AM RBC Initiates Coverage on Several Drug Makers

Apr 21, 2009 11:03 AM Buckingham Research Maintains a 'Strong Buy' on Mylan (MYL); Tweak Earning Model

Mar 20, 2009 08:22 AM Citi Reiterates a 'Buy' Rating on Teva Pharmaceutical (TEVA)

Mar 13, 2009 08:47 AM UBS Initiates Coverage on Several Drug Manufacturers

Feb 25, 2009 07:28 AM Credit Suisse Starts Coverage On Generic Drugs; AGN, MYL, TEVA Rated Outperform

Feb 23, 2009 07:44 AM Barclays Upgrades Mylan (MYL) to Overweight

Jan 21, 2009 09:46 AM Citi Initiates Coverage on Mylan (MYL) with a Buy

Dec 17, 2008 08:37 AM Collins Stewart Initiates Coverage on Specialty Pharma Companies

Dec 17, 2008 08:16 AM J.P. Morgan Initiates Coverage on Mylan (MYL) with an Overweight

Nov 12, 2008 07:25 AM Morgan Stanley Starts Mylan (MYL) at Overweight

Sep 25, 2008 07:55 AM Needham & Co Initiates Coverage on Drugs - Generic

Sep 24, 2008 05:28 PM Stanford Starts Mylan (MYL) at Buy

Sep 22, 2008 07:53 AM Wachovia Upgraded the Generic Drug Sector to Overweight; Ups TEVA and WPI to Overweight

Jul 18, 2008 02:03 PM Wachovia Comments on Mylan (MYL) After TEVA/BRL Merger

Jun 13, 2008 07:48 AM Caris & Co. Initiates Coverage on Mylan (MYL) with a Buy

May 30, 2008 02:15 PM Buckingham Research Upgrades Mylan (MYL) to Strong Buy

Mar 14, 2008 07:53 AM Citi Upgrades Mylan (MYL) to Buy

Feb 7, 2008 09:34 AM David Moenning's Daily State of the Markets: 2/7

Feb 7, 2008 09:02 AM Goldman Sachs removed Mylan (MYL) from its Conviction Buy list

Jan 9, 2008 07:35 AM Morgan Stanley Upgrades Mylan (MYL) to Overweight

Dec 18, 2007 08:10 AM Banc of America Initiates Coverage on Mylan (MYL) with a Buy

Nov 27, 2007 07:16 AM Goldman Sachs upgrades Mylan (MYL) to Buy

Nov 21, 2007 12:50 PM Merrill Lynch upgrades Mylan (MYL) to Buy

Nov 15, 2007 07:23 AM Bernstein upgrades Mylan (MYL) to Outperform

Sep 10, 2007 08:13 AM Credit Suisse upgrades Mylan Labs (MYL) to Outperform

Sep 10, 2007 07:25 AM UBS upgrades Mylan Labs (MYL) to Buy

Mar 27, 2007 07:46 AM Merrill Lynch upgrades Mylan Labs (MYL) to Neutral

Jan 18, 2007 08:19 AM Goldman Sachs downgrades Mylan Labs (MYL) to Neutral

Oct 31, 2006 09:43 AM Citigroup Downgrades Mylan Labs (MYL) to Hold

Aug 25, 2006 07:40 AM Banc of America Downgrades Mylan Labs (MYL) to Sell

Aug 18, 2006 12:55 PM S&P Equity Research Downgrades Mylan Labs (MYL) to Hold

Aug 8, 2006 07:31 AM Wachovia downgrades Mylan Labs (MYL) to Market Perform

Aug 7, 2006 02:56 PM Mylan Laboratories (MYL) Reaffirms FY EPS Outlook After Stock Falls in Mid-day Action

Jul 26, 2006 01:08 PM Merrill Lynch downgrades Mylan Laboratories Inc. (NYSE: MYL) to Neutral

Jun 29, 2006 09:47 AM Credit Suisse Initiates Coverage on Specialty Pharmaceuticals

Apr 19, 2006 07:51 AM Lehman Brothers downgrades Mylan (MYL) to Equal Weight

Feb 3, 2006 07:32 AM Wachovia upgrades MYL to Outperform

Jan 12, 2006 09:44 AM Buckingham upgrades FRX to Accumulate

Jan 6, 2006 07:14 AM Prudential Starts MYL at Neutral

Jan 5, 2006 01:11 AM Citigroup offers six predictions for specialty pharma in 2006

Dec 9, 2005 08:07 AM UBS Initiates MYL

Dec 9, 2005 07:24 AM UBS Starts MYL at Buy

Dec 6, 2005 07:33 AM Prudential Starts MYL at Neutral

Nov 4, 2005 07:57 AM Citigroup Starts MYL at Buy